eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


4/2023
vol. 22
 
Share:
Share:
Original paper

Relation between vitamin D and adolescents’ serum prolactin

Ainur Amanzholkyzy
1
,
Ainur Donayeva
1
,
Dinara Kulzhanova
1
,
Ibrahim A. Abdelazim
2
,
Talgar Abilov
1
,
Zhenisbek Baubekov
3
,
Ihab I. Samaha
4

  1. Department of Normal Physiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  2. Department of Obstetrics and Gynecology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
  3. Department of Pediatric Surgery, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  4. Department of Obstetrics and Gynecology, Faculty of Medicine, Helwan University, Cairo, Egypt
Menopause Rev 2023; 22(4): 202-206
Online publish date: 2023/12/21
Article file
- Relation between (2).pdf  [0.13 MB]
Get citation
 
PlumX metrics:
 

Introduction

The prolactin (PRL) has a variety of biological functions in addition to its role in lactation, including development of myelin sheath of the central nervous system neuronal axons and lung surfactant [13].

The secretion of PRL from the lactotrophs of the anterior pituitary gland is regulated by different regulatory mechanisms [4] and by internal and external factors [5].

Normally, the PRL secretion is under the inhibitory control of dopamine [5]. Different peptides and growth factors can stimulate the PRL secretion either through its inhibitory action on dopamine or through direct effect on the PRL secreting lactotrophs [5].

Lactation, stress and steroid hormones such as the ovarian estrogen increase the PRL production [6].

The thyroid releasing hormone (TRH) increases the thyroid stimulating hormone (TSH) secretion which subsequently increases the PRL secretion [7].

Vitamin D (Vit. D) deficiency was reported with Hashimoto’s thyroiditis (HT) [8, 9]. Appunni et al. recently found 25.6% of their studied participants with hypothyroidism had deficient Vit. D compared to 20.6% of healthy controls [10]. Appunni et al. also reported increased odds of hypothyroidism among Vit. D deficient participants [10].

The relation between Vit. D and PRL are conflicting in the previous studies. Although, Saki et al. found the PRL was more potent in increasing the serum 1.25(OH)2D than estrogen in animal model [11], and Törnquist et al. found the PRL secretion increased from the animal cells incubated with 1.25(OH)2D [12].

Haug et al. found the treatment of animal cells with 1.25(OH)2D caused an inhibition on PRL secretion [13]. The 25(OH)D is the most extensively used biomarker to measure the serum Vit. D [14]. Therefore, this cross-section research designed to detect whether there is a relation between Vit. D and adolescents’ serum PRL or not.

Material and methods

Hundred and seventy-six (176) school attendant adolescent girls were recruited for this cross-sectional research which was conducted in West Kazakhstan (Aktobe) over two years (2021–2022) to detect whether there is a relation between Vit. D and adolescents’ serum PRL or not.

The adolescents were recruited for the current research, after the ethics committee of West Kazakhstan Medical University (WKMU) approval and after informed consent from the adolescents and their guardians.

After thorough evaluation, the weight and height of the studied adolescents were measured to calculate the body mass index (BMI) [detected from the adolescents’ weight divided by meters-squared height (kg/m2)] [15, 16].

Inclusion criteria include adolescents (12–18 years-old), with regular menstrual cycles, normal BMI (18.5–24.9), without any known chronic or endocrine disorders.

Exclusion criteria include adolescents < 12 years-old or >18 years-old, underweight (BMI ≤ 18.5), overweight (BMI 25–29.9) or obese (BMI > 30) [15, 17], with irregular menstrual cycles, known medical disorders (i.e., diabetes, or hypertension), known endocrine disorders (i.e., thyroid, or hyperprolactinemia), and received exogenous hormones within the last year.

Regular menstrual cycles are defined as menstrual flow on regular basis every 21–35 days. Diabetes defined according to the American Diabetic Association as metabolic disorders due to defective insulin secretion or action. Diabetes diagnosed when the glycosylated hemoglobin (HbA1C) is ≥ 6.5% and fasting plasma sugar is ≥ 126 mg/dl or 2-hrs. plasma sugar is ≥ 200 mg/dl [18].

Hypertension diagnosed when the blood pressure is ≥ 140 mm Hg systolic and/or ≥ 90 mm Hg diastolic (on two separate sessions) [19].

Blood samples were taken from adolescents to measure TSH (normal 0.4–4.0 mIU/ml) [20], free thyroxine [T4 (normal 0.9–2.3 ng/dl)], PRL (normal < 29 ng/ml) [21], HbA1C (normal < 6.5%) [14] and 25(OH)D. The clinical hypothyroidism was diagnosed with high TSH and low free T4 [20].

The adolescents` blood was centrifugated and stored at –20°C for the quantitative 25(OH)D evaluation. The 25(OH)D level was measured using the Architect (Abbott, Longford, Ireland). The Architect 25(OH)D evaluation is a delayed 1-step chemiluminescence microparticles evaluation uses the Architect 25(OH)D Reagent Kit. The microparticles contains a sheep anti-25(OH)D antibody, and a biotinylated 25(OH)D anti-biotin antibodies-labelled conjugate complex [22].

Vitamin D deficiency was diagnosed when the serum 25(OH)D was > 20 ng/ml, while serum 25(OH)D > 30 ng/ml was considered as normal serum Vit. D [22].

The studied adolescent girls were classified into study group [25(OH)D deficient (88 adolescents)] and controls [normal 25(OH)D (88 adolescents)]. The acquired adolescents’ variables were analyzed to detect whether there is a relation between Vit. D and adolescents’ serum PRL or not.

Statistical analysis

The G Power 3.1.9.7 with 0.05 probability, 0.95% power, 0.5 sample size and Student t-test for statistical analysis was used for sample size calculation [23, 24]. The variables of the studied adolescent girls were checked for normal distribution using the Shapiro-Francia test [25] before statistical analysis. The acquired adolescents’ variables were analyzed using the Student t-test and Pearson’s correlation. p < 0.05 considered significant.

Ethical considerations

Adolescents included in this research, after the ethics committee of WKMU approval (No. 10–04 October 2020) and after informed consent from the adolescents and their guardians.

Grant funding for scientific and/or technical projects for the years 2021–2022- KZ- IRN AP09563004 – Supervisor (AA).

Results

Hundred and seventy-six school attendant adolescent girls between 12–18 years-old were recruited for this cross-sectional research to detect whether there is a relation between Vit. D and adolescents’ serum PRL or not.

The studied adolescents were classified into study group [25(OH)D deficient (88 adolescents)] and controls [normal 25(OH)D (88 adolescents)].

The was no difference between the study group and controls regarding the mean age (15.9 ±1.27 years in the study group vs. 15.99 ±1.1 for the controls), (p = 0.09).

About 85.2% (75/88) and 14.8% (13/88) of the studied adolescents in the study group were high-school and mid-school attendants, respectively compared to 86.4% (76/88) and 13.6% (12/88) of the controls (p = 1.0 and 0.85, respectively). About 76.1% (67/88) and 21.6% (19/88) of the studied adolescents in the study group have average and above average family income, respectively compared to 71.6% (63/88) and 23.9% (21/88) of the controls (p = 0.79 and 0.77, respectively), and 2.3% (2/88) of the studied adolescents in the study group have below average family income compared to 4.5% (4/88) of the controls (p = 0.4) (Table 1). The average family income/month in the Republic of Kazakhstan is 770 US dollars/month [26].

Table 1

The studied adolescents` socioeconomic characteristics, weight, height, body mass index, 25(OH)D, prolactin, and thyroid profile

Parameters25(OH)D deficient group
Study group, N = 88 adolescents
Normal 25(OH)D group
Controlos, N = 88 adolescentes
p-value (95% CI)
Age (years)15.9 ±1.2715.99 ±1.10.09 (–0.4, –0.09, 0.3)
> 12 to < 15 years16/88 (18.2%)13/88 (14.8%)0.6
> 15 to < 18 years72/88 (81.8%)75/88 (85.2%)0.85
Education
Mid school13/88 (14.8%)12/88 (13.6%)0.85
High school75/88 (85.2%)76/88 (86.4%)1.0
Family income**
Above average19/88 (21.6%)21/88 (23.9%)0.77
Average67/88 (76.1%)63/88 (71.6%)0.79
Below average2/88 (2.3%)4/88 (4.5%)0.4
Weight [kg]58.5 ±2.158.0 ±2.90.9 (–0.25, 0.5, 1.25)
Height [cm]157.5 ±1.6157.7 ±2.30.9 (–0.79, –0.2, 0.39)
BMI [kg/m2]23.5 ±0.723.26 ±0.960.9 (–0.01, 0.24, 0.49)
25(OH)D [ng/ml]13.8 ±2.535.6 ±2.020.02* (–22.5, –21.8, –21.1)
Serum PRL [ng/ml]47.5 ±7.610.8 ±5.10.0001* (34.77, 36.7, 38.6)
TSH [mIU/ml]3.73 ±1.452.67 ±1.00.0003* (0.69, 1.06, 1.4)
Free T4 [ng/dl]1.4 ±0.61.5 ±0.40.0001* (–0.25, –0.1, 0.05)

BMI – body mass index, CI – confidence Interval, PRL – prolactin, TSH – thyroid stimulating hormone, T4 – thyroxine

* Significant difference. 25(OH)D: 25-hydroxy vitamin D

** Average family income is 770 US dollars/month according to the National Bank of the Republic of Kazakhstan 2023

χ2 test was used for statistical analysis when data presented as number and percentage (%).

Student t-test used for statistical analysis when data presented as mean ± standard deviation (SD).

Data presented as mean ± SD and number and percentage (%)

There was no difference between the study group and controls regarding the mean weight (58.5 ±2.1 kg vs. 58.0 ±2.9, respectively), (p = 0.9), height (157.5 ±1.6 cm vs. 157.7 ±2.3, respectively), (p = 0.9) and BMI (23.5 ±0.7 kg/m2 vs. 23.26 ±0.96, respectively), (p = 0.9).

The 25(OH)D was statistically lower in the study group than normal controls (13.8 ±2.5 ng/ml vs. 35.6 ±2.02, respectively), [p = 0.02 (95% CI: –22.5, –21.8, –21.1)] (Table 1).

The serum TSH and PRL were statistically higher in the study group than normal controls (3.73 ±1.45 mIU/ml and 47.5 ±7.6 ng/ml vs. 2.67 ±1.0 and 10.8 ±5.1, respectively), (p = 0.0003, and p = 0.0001, respectively). The free T4 was statistically lower in the study group than normal controls (1.4 ±0.6 ng/ml vs. 1.5 ±0.4), [p = 0.0001 (95% CI: –0.25, –0.1, 0.05)] (Table 1).

Strong negative associations between the serum PRL and 25(OH)D [r = –0.803 (p < 0.00001)] (Fig. 1) and between the serum PRL and free T4 [r = –0.6959 (p < 0.00001)] (Fig. 2) were detected in this study. Additionally, there was a strong positive association between the serum PRL and TSH [r = 0.8137 (p < 0.00001)] (Fig. 3).

Fig. 1

Relation between the studied adolescents` serum prolactin and 25(OH)D

/f/fulltexts/PM/52106/MR-22-52106-g001_min.jpg
Fig. 2

Relation between the studied adolescents` serum prolactin and free thyroxine

T4 – thyroxine

/f/fulltexts/PM/52106/MR-22-52106-g002_min.jpg
Fig. 3

Relation between the studied adolescents` serum prolactin and thyroid stimulating hormone

TSH – thyroid stimulating hormone

/f/fulltexts/PM/52106/MR-22-52106-g003_min.jpg

Discussion

The relation between Vit. D and PRL are conflicting in the previous studies. Although, Saki et al. found the PRL was more potent in increasing the serum 1.25(OH)2D than estrogen in animal model [11], and Törnquist et al. found the PRL secretion increased from the animal cells incubated with 1.25(OH)2D [12].

Haug et al. found the treatment of animal cells with 1.25(OH)2D caused an inhibition on PRL secretion [13]. Therefore, hundred and seventy-six (176) school attendant adolescent girls between 12–18 years-old were recruited for this cross-sectional research to detect whether there is a relation between Vit. D and adolescents’ serum PRL or not. The studied adolescents were classified into study group [25(OH)D deficient (88 adolescents)] and controls [normal 25(OH)D (88 adolescents)].

The 25(OH)D is the most extensively used biomarker to measure the serum Vit. D [14]. It has a long half-life [14], and it reflects the cutaneous production and the intake of Vit. D [27].

The 1.25(OH)2D level is not ideal indicator for the Vit. D status because it is only decreased after severe Vit. D deficiency [27]. Additionally, it has a short half-life, and it is regulated by the PTH, calcium and phosphate [27].

The 25(OH)D relation to thyroid and prolactin disorders

Although, Saki et al. found the PRL was more potent in increasing the serum 1.25(OH)2D than estrogen in animal model [11] and Törnquist et al. found the PRL secretion increased from the animal cells incubated with 1.25(OH)2D [12].

The serum TSH and PRL in this study were statistically higher in the study group than normal controls (3.73 ±1.45 mIU/ml and 47.5 ±7.6 ng/ml vs. 2.67 ±1.0 and 10.8 ±5.1, respectively), (p = 0.0003, and p = 0.0001, respectively). A strong negative association between the serum PRL and 25(OH)D [r = –0.803 (p < 0.00001)] and a strong positive association between the serum PRL and TSH [r = 0.8137 (p < 0.00001)] were detected in this study.

Vitamin D deficiency was reported with hypothyroidism especially HT [8, 9]. Chao et al. found the TSH was significantly higher in 25(OH)D deficient participants than controls [28]. Bozkurt et al. found patients with hypothyroidism irrespective the hypothyroidism was due to autoimmune thyroiditis (AITDs) or not had a low Vit. D [29]. Kim et al. found the low Vit. D was independently associated with HT and high TSH [30]. Fang et al. confirmed a positive association between the antithyroid antibodies and Vit. D deficiency [31].

Moreover, Mackawy et al. reported a strong negative relation between Vit. D and TSH [32]. Recently, Appunni et al. analyzed 7943 participants and found that 25.6% of their studied participants with hypothyroid had deficient Vit. D compared to 20.6% of healthy controls [10]. Appunni et al. also reported increased odds of hypothyroidism among Vit. D deficient participants [10].

The hypothyroidism is associated with elevated TSH through the feedback mechanism on the thyrotropes of the anterior pituitary [33]. The thyroid stimulating hormone stimulates the anterior pituitary lactotrophs with subsequent increased PRL secretion [7].

Haug et al. found the treatment of animal cells with 1.25(OH)2D caused an inhibition on PRL secretion [13]. Additionally, Haug et al. found the 1.25(OH)2D inhibits the TRH and estrogens stimulation on PRL produ- ction [13].

Krysiak et al. [34] and Aboelnaga et al. [35] found that Vit. D administered to patients with prolactinoma increases the 25(OH)D and reduces the serum PRL [34].

The Haug et al. [13], and Krysiak et al. [34] findings support the strong negative association between the serum PRL, and 25(OH)D found in this study.

The association between Vit. D and serum PRL and the effect of Vit. D intake on the serum PRL need to be confirmed in further studies.

This research was the first cross-sectional research conducted in West Kazakhstan (Aktobe) to detect the relation between Vit. D and adolescents’ serum PRL. The serum TSH and PRL were statistically higher in the studied adolescents than normal controls. A strong negative association between the serum PRL and 25(OH)D and a strong positive association between the serum PRL and TSH were detected in this study. Failure to detect the causes of hyperprolactinemia in the studied adolescents and the effect of Vit. D intake on the serum PRL were the limitations of this study.

Conclusions

A strong negative association between the serum PRL and 25(OH)D and a strong positive association between the serum PRL and TSH were detected in this study. This study recommends further studies to confirm the relation between Vit. D and PRL and screening Vit. D deficient adolescents for PRL and thyroid disorders.

Disclosure

The authors report no conflict of interest.

References

1 

Al-Kuraishy HM, Al-Gareeb AI, Butnariu M, Batiha GE. The crucial role of prolactin-lactogenic hormone in COVİD-19. Mol Cell Biochem 2022; 477: 1381-1392.

2 

Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-1631.

3 

Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998; 19: 225-268.

4 

Bernichtein S, Touraine P, Goffin V. New concepts in prolactin biology. J Endocrinol 2010; 206: 1-11.

5 

Qazzaz Mohannad E, Abed Mohammed N, Alassaf Fawaz A, Jasim Mahmood HM, Alfahad M. Insights into the perspective correlation between vitamin D and regulation of hormones: sex hormones and prolactin. Curr Issue Pharma Med Sci 2021; 34: 192-200.

6 

Cabrera-Reyes EA, Limón-Morales O, Rivero-Segura NA, Camacho-Arroyo I, Cerbón M. Prolactin function and putative expression in the brain. Endocrine 2017; 57: 199-213.

7 

Bahar A, Akha O, Kashi Z, Vesgari Z. Hyperprolactinemia in association with subclinical hypothyroidism. Caspian J Intern Med 2011; 2: 229-233.

8 

Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid 2011; 21: 891-896.

9 

Veldurthy V, Wei R, Oz L, Dhawan P, Jeon YH, Christakos S. Vitamin D, calcium homeostasis and aging. Bone Res 2016; 4: 16041.

10 

Appunni S, Rubens M, Ramamoorthy V, et al. Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007–2012. BMC Endocr Disord 2021; 21: 224.

11 

Saki F, Sadeghian F, Kasaee SR, Koohpeyma F, Ranjbar Omrani GH. Effect of prolactin and estrogen on the serum level of 1,25-dihydroxy vitamin D and FGF23 in female rats. Arch Gynecol Obstet 2020; 302: 265-271.

12 

Törnquist K. Effect of 1,25-dihydroxyvitamin D3 on rat pituitary prolactin release. Acta Endocrinol (Copenh) 1987; 116: 459-464.

13 

Haug E, Pedersen JI, Gautvik KM. Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cells. Mol Cell Endocrinol 1982; 28: 65-79.

14 

Ramasamy I. Vitamin D metabolism and guidelines for vitamin D supplementation. Clin Biochem Rev 2020; 41: 103-126.

15 

Abdelazim IA, Amer OO, Farghali M. Common endocrine disorders associated with the polycystic ovary syndrome. Prz Menopauz 2020; 19: 179-183.

16 

Abdelazim IA, Alanwar A, AbuFaza M, et al. Elevated and diagnostic androgens of polycystic ovary syndrome. Prz Menopauz 2020; 19: 1-5.

17 

Adilgereyeva AS, Abdelazim IA, Zhurabekova GA, El-Ghazaly TE. Morphological parameters of ovarian masses and accuracy of the risk of malignancy index in diagnosing ovarian malignancy. Prz Menopauz 2022; 21: 81-91.

18 

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37: S81-S90.

19 

Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020; 75: 1334-1357.

20 

Poppe K, Bisschop P, Fugazzola L, Minziori G, Unuane D, Weghofer A. 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction. Eur Thyroid J 2021; 9: 281-295.

21 

Abdelazim IA, Kanshaiym S. Abdelazim and Sakiyeva endocrinopathy associated with polycystic ovary syndrome: case reports. J Family Med Prim Care 2019; 8: 3039-3041.

22 

Gromova O, Doschanova A, Lokshin V, et al. Vitamin D deficiency in Kazakhstan: cross-sectional study. J Steroid Biochem Mol Biol 2020; 199: 105565.

23 

Mohammed WE, Abbas MM, Abdelazim IA, Salman MM. Sildenafil citrate as an adjuvant to clomiphene citrate for ovulation induction in polycystic ovary syndrome: crossover randomized controlled trial. Prz Menopauz 2022; 21: 20-26.

24 

Obaid M, Abdelazim IA, AbuFaza M, Al-Khatlan HS, Al-Tuhoo AM, Alkhaldi FH. Efficacy of ferric carboxy maltose in treatment of iron deficiency/iron deficiency anaemia during pregnancy. Prz Menopauz 2023; 22: 16-20.

25 

Mbah AK, Paothong A. Shapiro-Francia test compared to other normality test using expected p-value. J Statistical Computation Simulation 2014; 85: 3002-3016

26 

27 

Turck D, Bohn T, Castenmiller J, et al. Safety of vitamin D2 mushroom powder as a Novel food pursuant to Regulation (EU) 2015/2283 (NF 2019/1471). EFSA J 2022; 20: e07326.

28 

Chao G, Zhu Y, Fang L. Correlation between Hashimoto’s thyroiditis-related thyroid hormone levels and 25-hydroxy vitamin D. Front Endocrinol 2020; 11: 4.

29 

Bozkurt NC, Karbek B, Ucan B, et al. The association between severity of vitamin D deficiency and Hashimoto’s thyroiditis. Endocr Pract 2013; 19: 479-484.

30 

Kim D. Low vitamin D status is associated with hypothyroid Hashimoto’s thyroiditis. Hormones (Athens) 2016; 15: 385-393.

31 

Fang F, Chai Y, Wei H, et al. Vitamin D deficiency is associated with thyroid autoimmunity: results from an epidemiological survey in Tianjin, China. Endocrine 2021; 73: 447-454.

32 

Mackawy AM, Al-Ayed BM, Al-Rashidi BM. Vitamin d deficiency and its association with thyroid disease. Int J Health Sci (Qassim) 2013; 7: 267-275.

33 

Available from: https://www.ncbi.nlm.nih.gov/books/NBK499850/ (accessed 01.05.2023]

34 

Krysiak R, Kowalska B, Szkróbka W, Okopień B. The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: a pilot study. Exp Clin Endocrinol Diabetes 2015; 123: 446-450.

35 

Aboelnaga MM, Abdullah N, El Shaer M. 25-hydroxyvitamin D correlation with prolactin levels and adenoma size in female patients with newly diagnosed prolactin secreting adenoma. Endocr Metab Immune Disord Drug Targets 2017; 17: 219-225.

Copyright: © 2023 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.